
ServiceNow Consultancy CoreX Signals Next Phase of Enterprise Growth Through Rebrand
"Enterprises want the depth of expertise they associate with major consultancies, but they also want the responsiveness and innovation they get from specialists. The CoreX brand represents our ability to deliver both." - Rick Wright, CEO, CoreX Share
An Elite ServiceNow Partner, CoreX now sits as one of the top 5% of all ServiceNow partners for total certifications, platform capabilities, and innovative, industry-first offerings. The announcement timing reflects the company's confidence that its combination of strategic acquisitions and proven leadership has built a consultancy capable of delivering 'Big Four' firm capabilities, while maintaining the agility and specialized client focus that have driven its rapid growth, led by one of the most experienced ServiceNow leadership teams in the ecosystem.
'The new CoreX digital identity represents where we are today, and where we're heading,' said Meghan Lockwood, co-founder and Head of Marketing and People, CoreX. 'We've evolved from a specialized practice to a comprehensive ServiceNow consultancy that can compete on any engagement while maintaining the client intimacy and innovation that larger firms often struggle to deliver.'
Proven Leadership Validates Market Position
The firm's rebrand is supported by a leadership team (from the founders to newly acquired executives) with collective ServiceNow experience that spans the platform's entire evolution and reflects deep functional and industry expertise across global markets.
CoreX's executive team includes some of the most respected names in the ecosystem, each bringing a unique perspective that has shaped the company's ability to deliver at scale while maintaining agility and innovation.
CEO Rick Wright brings three decades of technology transformation experience, including deep involvement in ServiceNow's evolution from emerging platform to enterprise standard. At KPMG, he built the first Systems Integrator ServiceNow practice in 2010, and later served as global leader for ServiceNow's professional services and customer success organizations from 2018 through 2022. His reputation as a trusted advisor among CIOs and his ability to translate technical capabilities into clear business value have been central to CoreX's ability to secure and deliver complex, enterprise-scale engagements.
Ross Rexer, Head of Service Delivery, brings a comprehensive understanding of both ServiceNow strategy and implementation. His background working at an executive level with ServiceNow partners since 2010 and serving as a global leader on ServiceNow's Customer Outcomes team has proven instrumental in acquisition integration and delivery scalability across the organization.
Meghan Lockwood, Co-Founder and Head of Marketing and People, has established herself as a strategic force in ServiceNow practice development. Her operational excellence approach and experience scaling ServiceNow capabilities across Fortune 500 organizations provide the foundation for CoreX's ambitious growth plans. She previously served on the executive team at Acorio, where she helped lead a $7M to $50M growth trajectory and post-acquisition integration into a global IT leader.
Steven Dabrowski, Co-Founder, Finance and Supply Chain Advisory, leads solution architecture for some of CoreX's most complex Source-to-Pay transformations. His technical insight and advisory experience position CoreX as a strategic partner to finance, procurement, and operations leaders tackling ERP modernization.
Eric Jones, Head of Global Sales, brings a consultative, outcomes-driven approach to client relationships from his decade-plus in sales leadership across the ServiceNow ecosystem, including stints at KPMG and Cask. His leadership ensures strategic alignment between client needs, platform potential, and CoreX's unique delivery capabilities.
Together with their new peers from recent acquisitions (listed below), this executive bench validates CoreX's position as a premier consultancy capable of delivering the capabilities of a global systems integrator while maintaining the innovation and client intimacy of a specialist firm.
Strategic Acquisitions Drive Comprehensive Capabilities
The CoreX rebrand follows a series of strategic acquisitions that have expanded the firm's ServiceNow disciplines while maintaining quality and cultural fit. Rather than pursuing scale through large acquisitions, the company has focused on targeted acquisitions that bring specific platform expertise and proven client relationships, and will continue to do so.
This acquisition strategy has enabled CoreX to rapidly develop comprehensive ServiceNow capabilities across multiple business functions while avoiding the integration challenges that often diminish the value of consultancy mergers. Each acquired team maintains its specialized focus while contributing to the firm's broader transformation capabilities.
Fritz Byam, Head of Industrial Solutions and former CEO of ITS Partners, brings deep expertise in manufacturing, operational technology, and asset management. His leadership is shaping CoreX's go-to-market strategy for industrial transformation, which is a growing focus area for global enterprises modernizing legacy operations.
Fernando Gordoa, President and General Manager for Latin America & Iberia and former CEO of Volteo Digital, is leading CoreX's expansion into international markets and brings deep operational expertise, entrepreneurial leadership, strategic thinking, and a proven track record scaling ServiceNow delivery across global markets.
Monica Hidalgo, Head of Global Center of Excellence and Managed Services (who was recently named one of the Top 50 Global Leaders in AI by Channel Insider), drives global delivery innovation, governance, and solution design, and orchestrates cross-functional teams dedicated to accelerating customer success through ServiceNow-powered digital transformations.
Jay Wigard, Head of Innovation and AI Strategy, ensures technical alignment across the company's solution portfolio. His focus on modern architectures, innovation strategy, and cross-workflow enablement is critical to CoreX's ability to help clients scale the Now Platform enterprise-wide.
Coming to CoreX through the acquisitions of Volteo and ITS Partners, these leaders now sit on the CoreX Global Leadership team and are influencing future acquisitions based on the CoreX portfolio. The firm's approach of identifying complementary capabilities rather than competitive overlaps has created a model for sustainable expansion in the specialized consulting market.
Market Timing and Competitive Landscape
The rebrand comes at a pivotal moment for the ServiceNow ecosystem, as enterprises accelerate AI-driven automation initiatives and seek consultancies capable of managing complex, multi-workload implementations. CoreX's positioning as a specialized firm with comprehensive capabilities addresses a growing market demand for alternatives to traditional large consultancy models.
"Enterprises want the depth of expertise they associate with major consultancies, but they also want the responsiveness and innovation they get from specialists," Wright said. "The CoreX brand represents our ability to deliver both."
The consulting landscape for ServiceNow has become increasingly sophisticated as the platform has evolved beyond ITSM into enterprise-wide business automation. CoreX's rebrand reflects its readiness to handle these complex transformations while maintaining the client relationships and cultural agility that have driven its growth.
ServiceNow Ecosystem Impact
The firm's combination of proven leadership, strategic acquisitions, and comprehensive capabilities creates a new model for how specialized consultancies can scale while maintaining their core advantages. The rebrand also signals CoreX's intention to play a larger role in ServiceNow ecosystem development, with the firm's leadership team actively contributing to platform evolution discussions and best practice development.
About CoreX
Founded in 2023 by ecosystem veterans, CoreX is a global ServiceNow consultancy specializing in business-focused transformation that unlocks hidden value from the Now Platform. Backed by unmatched industry leadership, extensive functional experience, and the most seasoned ServiceNow team in the ecosystem, CoreX delivers strategic guidance and AI-enabled innovation to power sustained success. Learn more at www.corexcorp.com.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
21 minutes ago
- Business Wire
Deadline Soon: 3D Systems Corporation (DDD) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz reminds investors of the upcoming deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO LOST MONEY ON 3D SYSTEMS CORPORATION (DDD), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT. What Happened? On March 26, 2025, 3D Systems released its fourth quarter and full year 2024 financial results, missing consensus estimates in non-GAAP earnings-per-share and sales revenue, citing 'lowers hardware systems sales due to macroeconomic factors that are negatively impacting demand.' The Company also reported a '$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program." The Company disclosed that "[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing . . . which led to refinement of the milestone technical criteria." On this news, 3D Systems' stock price fell $0.57, or 21%, to close at $2.15 per share on March 27, 2025, thereby injuring investors. Then, on May 12, 2025, after market hours, 3D Systems released its first quarter 2025 financial results, missing consensus estimates due, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. The Company further disclosed that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68, or 26.6%, to close at $1.87 per share on May 13, 2025, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired 3D Systems securities between August 13, 2024 and May 12, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is August 12, 2025. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us: Frank R. Cruz The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Email us at: info@ Call us at: 310-914-5007 Visit our website at Follow us for updates on Twitter: If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Business Wire
21 minutes ago
- Business Wire
Deadline Soon: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz reminds investors of the upcoming August 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Rocket Pharmaceuticals, Inc. ('Rocket' or the 'Company') (NASDAQ: RCKT) securities between , inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO LOST MONEY ON ROCKET PHARMACEUTICALS, INC. (RCKT), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT. What Happened? On May 27, 2025, Rocket disclosed that the FDA had placed a clinical hold on the Phase 2 pivotal trial of its Danon disease treatment, RP-A501, after at least one patient died following a substantive amendment to the protocol that the Company had not disclosed until after the Serious Adverse Event ('SAE') occurred. On this news, Rocket's stock price fell $3.94, or 62.8%, to close at $2.33 per share on May 27, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Rocket knew SAEs, including death of participants enrolled in the study, were a risk; (2) Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Rocket securities between September 17, 2024 and May 26, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is August 11, 2025. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us: Frank R. Cruz The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Email us at: info@ Call us at: 310-914-5007 Visit our website at Follow us for updates on Twitter: If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Business Wire
21 minutes ago
- Business Wire
Deadline Approaching: Novo Nordisk A/S (NVO) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Novo Nordisk A/S ('Novo Nordisk' or the 'Company') (NYSE: NVO) securities between May 7, 2025, to July 28, 2025, inclusive (the 'Class Period'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NOVO NORDISK A/S (NVO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On July 29, 2025, Novo Nordisk cut its previously issued fiscal year 2025 guidance, lowering sales growth from 13-21% to 8-14%, and operating profit from 16-24% to 10-16%. The Company cited lower growth expectations for both Ozempic and Wegovy on the back of a slowdown in market expansion, competition, and the alleged continued use of compounded GLP-1s. On this news, Novo Nordisk's stock price fell $15.06, or 21.8%, to close at $53.94 per share on July 29, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Novo Nordisk repeatedly ignored and minimized the significance of the personalization exception for GLP-1 compounding, greatly overestimated its ability to capture patients coming off of compounded treatments, and was ultimately ill equipped to capitalize upon the purported significant unmet patient population; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Novo Nordisk securities during the Class Period, you may move the Court no later than September 30, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.